Print Departments and specialties Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition Cardiovascular Medicine Clinical Genomics Gastroenterology and Hepatology Hereditary Hemorrhagic Telangiectasia (HHT) Clinic Liver-Lung Program Neurology Neurosurgery Neurovascular (Cerebrovascular) Surgery Otolaryngology (ENT)/Head and Neck Surgery Pulmonary Medicine Radiology Areas that research this condition Neurologic Surgery Neurology Research Otolaryngology — Head and Neck Surgery Research Radiology Research ResearchMayo Clinic researchers are studying how HHT affects the nose, brain, lungs, digestive tract and liver. They're also assessing the role of anti-angiogenic medicines. These medicines keep blood vessels from forming and manage serious HHT-related bleeding. They include bevacizumab (Avastin), given through a vein. They also include medicines taken by mouth such as pazopanib (Votrient), pomalidomide (Pomalyst) and tacrolimus (Prograf, Protopic, others). Mayo Clinic has been recruiting people for the Brain Vascular Malformations Consortium (BVMC) study. Mayo Clinic also is recruiting for a biorepository of patient blood samples that can help researchers find better diagnostic, prognostic and treatment options for this rare disease. PublicationsSee a list of publications about hereditary hemorrhagic telangiectasia by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. Research Profiles Edit search filters close Narrow your search By location Arizona Florida Minnesota View all View all physicians • All Locations Kamath, Patrick S. M.D. Minnesota By Mayo Clinic Staff Hereditary hemorrhagic telangiectasia care at Mayo Clinic Request an appointment Diagnosis & treatmentCare at Mayo Clinic Feb. 07, 2025 Print Living with hereditary hemorrhagic telangiectasia? Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community. Blood Cancers & Disorders Discussions Have you ever had hiccups with or after chemotherapy? 118 Replies Mon, Nov 10, 2025 chevron-right Living with MDS (Myelodyplastic Syndromes) 234 Replies Sat, Nov 08, 2025 chevron-right Diagnosed: MGUS 137 Replies Fri, Nov 07, 2025 chevron-right See more discussions Related Products & Services A Book: Mayo Clinic Family Health Book Newsletter: Mayo Clinic Health Letter — Digital Edition Show more products and services from Mayo Clinic Hereditary hemorrhagic telangiectasiaSymptoms&causesDiagnosis&treatmentDoctors&departmentsCare atMayoClinic Research: It's all about patients Show transcript for video Research: It's all about patients [MUSIC PLAYING] Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight. CON-20155449 Diseases & Conditions Hereditary hemorrhagic telangiectasia